NAS
ATRC icon

Nykredit A/S’s AtriCure ATRC Stock Holding History

Nykredit A/S’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.1K Buy
+612
New +$17.2K ﹤0.01% 1770

Other funds holding ATRC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Nykredit A/S's ATRC Position: Q2 2026 in Review

Nykredit A/S opened a new position in AtriCure (ATRC) in Q2 2026: 612 shares worth $17.1K. The stake represents ﹤0.01% of the portfolio and ranks #1770 among its holdings.

174 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Nykredit A/S held 612 shares of AtriCure worth $17.1K as of Q2 2026.
  • AtriCure was a new Nykredit A/S position in Q2 2026.
  • AtriCure made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #1770 holding.
  • 174 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.